NASDAQ:AXSM

Axsome Therapeutics News Headlines

$66.39
-1.18 (-1.75 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$65.78
$67.97
50-Day Range
$50.63
$67.57
52-Week Range
$50.05
$90.00
Volume261,666 shs
Average Volume343,071 shs
Market Capitalization$2.49 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.53

Axsome Therapeutics (NASDAQ AXSM) News Headlines Today

SourceHeadline
Axsome Therapeutics (NASDAQ:AXSM) Now Covered by Analysts at Berenberg BankAxsome Therapeutics (NASDAQ:AXSM) Now Covered by Analysts at Berenberg Bank
marketbeat.com - June 10 at 7:29 AM
Axsome Therapeutics (NASDAQ:AXSM) Price Target Increased to $105.00 by Analysts at Morgan StanleyAxsome Therapeutics (NASDAQ:AXSM) Price Target Increased to $105.00 by Analysts at Morgan Stanley
marketbeat.com - May 26 at 8:34 AM
Why this is an Awesome Time to Buy Axsome TherapeuticsWhy this is an Awesome Time to Buy Axsome Therapeutics
marketbeat.com - March 1 at 11:17 AM
Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 6.6%Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 6.6%
americanbankingnews.com - June 10 at 12:36 PM
Axsome Therapeutics (NASDAQ:AXSM) Coverage Initiated by Analysts at Berenberg BankAxsome Therapeutics (NASDAQ:AXSM) Coverage Initiated by Analysts at Berenberg Bank
americanbankingnews.com - June 10 at 8:30 AM
Why Is Axsome (AXSM) Up 14.7% Since Last Earnings Report?Why Is Axsome (AXSM) Up 14.7% Since Last Earnings Report?
finance.yahoo.com - June 9 at 1:18 PM
Noteworthy Wednesday Option Activity: AXSM, CELH, IMAXNoteworthy Wednesday Option Activity: AXSM, CELH, IMAX
nasdaq.com - June 2 at 5:46 PM
Axsome Therapeutics (NASDAQ:AXSM) PT Raised to $105.00 at Morgan StanleyAxsome Therapeutics (NASDAQ:AXSM) PT Raised to $105.00 at Morgan Stanley
americanbankingnews.com - May 26 at 10:24 AM
AXSM210618C00062500 (AXSM210618C00062500) stock price, news, quote & history – Yahoo FinanceAXSM210618C00062500 (AXSM210618C00062500) stock price, news, quote & history – Yahoo Finance
in.finance.yahoo.com - May 24 at 10:45 PM
Axsomes (AXSM) Q1 Earnings Top, AXS-05 Launch in FocusAxsome's (AXSM) Q1 Earnings Top, AXS-05 Launch in Focus
finance.yahoo.com - May 11 at 3:42 PM
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business UpdateAxsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 10:00 AM
Why Earnings Season Could Be Great for Axsome Therapeutics (AXSM)Why Earnings Season Could Be Great for Axsome Therapeutics (AXSM)
finance.yahoo.com - May 7 at 1:38 PM
Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health MonthAxsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month
finance.yahoo.com - May 7 at 8:38 AM
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
finance.yahoo.com - April 27 at 9:56 AM
FDA Begins Priority Review of Axsome Therapeutics Potential New Depression DrugFDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug
nasdaq.com - April 26 at 1:31 PM
Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive DisorderAxsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder
finance.yahoo.com - April 26 at 8:31 AM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Axsome Therapeutics, Inc. for Potential Breach of Fiduciary Duty ClaimsINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Axsome Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - April 24 at 1:54 PM
Is a Beat in Store for CRISPR (CRSP) This Earnings Season?Is a Beat in Store for CRISPR (CRSP) This Earnings Season?
msn.com - April 23 at 9:14 AM
Why Is Axsome (AXSM) Down 19.9% Since Last Earnings Report?Why Is Axsome (AXSM) Down 19.9% Since Last Earnings Report?
finance.yahoo.com - March 31 at 1:46 PM
Oversold Conditions For Axsome TherapeuticsOversold Conditions For Axsome Therapeutics
nasdaq.com - March 30 at 5:44 PM
Read This Before Selling Axsome Therapeutics, Inc. (NASDAQ:AXSM) SharesRead This Before Selling Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares
finance.yahoo.com - March 30 at 7:31 AM
1 Green Flag for Axsome Therapeutics1 Green Flag for Axsome Therapeutics
finance.yahoo.com - March 11 at 2:33 PM
InvestorNewsBreaks - Axsome Therapeutics, Inc. (NASDAQ: AXSM) Featured in Mizuho Securities Research ReportInvestorNewsBreaks - Axsome Therapeutics, Inc. (NASDAQ: AXSM) Featured in Mizuho Securities Research Report
marketwatch.com - March 5 at 7:44 PM
Axsomes (AXSM) Q4 Earnings Miss Estimates, Pipeline in FocusAxsome's (AXSM) Q4 Earnings Miss Estimates, Pipeline in Focus
finance.yahoo.com - March 2 at 2:30 PM
Axsome Therapeutics, Inc. (AXSM) Q4 2020 Earnings Call TranscriptAxsome Therapeutics, Inc. (AXSM) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 1 at 7:31 PM
Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateAxsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 1 at 8:21 AM
Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
finance.yahoo.com - February 16 at 12:05 PM
Forget Bitcoin: This Biotech Stock Is a Better Buy in 2021Forget Bitcoin: This Biotech Stock Is a Better Buy in 2021
finance.yahoo.com - February 10 at 8:37 AM
Axsome Therapeutics (AXSM) Shares Cross Above 200 DMAAxsome Therapeutics (AXSM) Shares Cross Above 200 DMA
nasdaq.com - February 4 at 1:16 PM
AXSM Feb 2021 55.000 putAXSM Feb 2021 55.000 put
ca.finance.yahoo.com - January 30 at 6:22 PM
AXSM Feb 2021 80.000 callAXSM Feb 2021 80.000 call
ca.finance.yahoo.com - January 30 at 8:16 AM
AXSM Feb 2021 87.500 putAXSM Feb 2021 87.500 put
ca.finance.yahoo.com - January 29 at 7:24 PM
AXSM Feb 2021 77.500 callAXSM Feb 2021 77.500 call
ca.finance.yahoo.com - January 29 at 7:24 PM
Is It Too Late to Get In On This Millionaire-Making Stock?Is It Too Late to Get In On This Millionaire-Making Stock?
finance.yahoo.com - January 27 at 9:18 AM
Axsomes (AXSM) Migraine Drug Shows Long-Term Safety in StudyAxsome's (AXSM) Migraine Drug Shows Long-Term Safety in Study
finance.yahoo.com - January 4 at 1:01 PM
Axsome Therapeutics Announces Positive Efficacy...Axsome Therapeutics Announces Positive Efficacy...
benzinga.com - December 31 at 8:30 AM
Axsome Reports Positive Results From Phase 3 Trial Of AXS-07 In Acute Treatment Of MigraineAxsome Reports Positive Results From Phase 3 Trial Of AXS-07 In Acute Treatment Of Migraine
nasdaq.com - December 31 at 8:30 AM
Axsome Therapeutics Begins Phase 3 Trial Of AXS-05 In Alzheimers Disease AgitationAxsome Therapeutics Begins Phase 3 Trial Of AXS-05 In Alzheimer's Disease Agitation
nasdaq.com - December 31 at 8:30 AM
Axsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease AgitationAxsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
finance.yahoo.com - December 31 at 8:30 AM
What Kind Of Shareholders Hold The Majority In Axsome Therapeutics, Inc.s (NASDAQ:AXSM) Shares?What Kind Of Shareholders Hold The Majority In Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shares?
finance.yahoo.com - December 30 at 8:46 AM
Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run?Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run?
markets.businessinsider.com - December 27 at 10:11 PM
Axsome Therapeutics Inc BuyAxsome Therapeutics Inc Buy
markets.businessinsider.com - December 26 at 9:08 PM
CRSP Jan 2021 110.000 putCRSP Jan 2021 110.000 put
uk.finance.yahoo.com - December 26 at 9:08 PM
AXSM Mar 2021 90.000 putAXSM Mar 2021 90.000 put
in.finance.yahoo.com - December 23 at 1:41 PM
Several High Impact Catalysts For Axsome In H1 2021Several High Impact Catalysts For Axsome In H1 2021
seekingalpha.com - December 23 at 8:40 AM
AXSM Mar 2021 115.000 callAXSM Mar 2021 115.000 call
in.finance.yahoo.com - December 22 at 11:57 PM
Noteworthy Tuesday Option Activity: BJRI, AXSM, GILDNoteworthy Tuesday Option Activity: BJRI, AXSM, GILD
nasdaq.com - December 22 at 6:56 PM
AXSM Jan 2021 77.500 putAXSM Jan 2021 77.500 put
in.finance.yahoo.com - December 21 at 11:55 PM
Axsome Therapeutics IncAxsome Therapeutics Inc
bloomberg.com - December 18 at 10:55 PM
AXSM Jan 2022 57.500 callAXSM Jan 2022 57.500 call
in.finance.yahoo.com - December 17 at 11:17 PM
Is AXSM A Good Stock To Buy Now?Is AXSM A Good Stock To Buy Now?
finance.yahoo.com - December 17 at 6:17 PM
AXSM Jan 2022 90.000 putAXSM Jan 2022 90.000 put
in.finance.yahoo.com - December 16 at 7:49 PM
The Daily Biotech Pulse: ASH Presentations, Axsomes Positive Midstage Readout, Follow-On OfferingsThe Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
benzinga.com - December 8 at 9:33 AM
This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.